Tests a home kit to screen people with type 2 diabetes for kidney disease
Compares home kits with standard lab orders to screen adults with diabetes.
Plain-language title generated from the registry record
Registry title: Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Key facts
- Where
- Ann Arbor, Birmingham, Duluth, Durham, Houston, St. Petersburg, and Temple, United StatesSee the 7 sites
Where in United States
- University of MichiganAnn Arbor, United StatesTaking people
- University of AlabamaBirmingham, United StatesTaking people
- Essentia HealthDuluth, United StatesTaking people
- Duke UniversityDurham, United StatesTaking people
- Houston MethodistHouston, United StatesTaking people
- Orlando HealthSt. Petersburg, United StatesTaking people
- Baylor Scott & WhiteTemple, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Duke University
- Trial code
- NCT06906627
- Record updated
- 1 October 2026
- Original description
IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.Read full original descriptionShow less
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD)
IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.
Inclusion: Adults with type 2 diabetes (T2D); Receiving primary care within the healthcare system, Primary Care Provider (PCP) visit within the past 24 months (any PCP provider, including APP); Lack of estimated glomerular filtration rate (eGFR) and/or urine albumin- creatinine ratio (UACR) measurement in the prior 15 months within the EHR.
Exclusion: Chronic kidney disease (CKD) diagnosis.
Screening Program-.